Meglumine antimoniate: Difference between revisions

Revision as of 03:35, 7 January 2014

Meglumine Antimoniate
GLUCANTIM^® WHO Prescribing Information
Description
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Meglumine antimonate

Overview

Meglumine antimoniate is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy.

It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

Brand Names

GLUCANTIM, GLUCANTIME (NOT AVAILABLE)

FDA Package Insert

Mechanism of Action

References

@@ Line 1: / Line 1: @@
-{{drugbox
+__NOTOC__
-| IUPAC_name        =
+{{Meglumine antimoniate}}
-| image             = Meglumine antimoniate major component 3D.png
+{{CMG}}
-| CAS_number        = 133-51-7
-| ATC_prefix        = P01
-| ATC_suffix        = CB01
-| PubChem           = 64953
-| DrugBank          =
-| chemical_formula  = Variable
-| molecular_weight  = Variable
-| bioavailability   =
-| protein_bound     =
-| metabolism        =
-| elimination_half-life =
-| excretion         =
-| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
-| pregnancy_US      =  <!-- A / B            / C / D / X -->
-| pregnancy_category=
-| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
-| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
-| legal_UK          =  <!-- GSL         / P       / POM / CD / Class A, B, C -->
-| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
-| legal_status      =
-| routes_of_administration =
-}}
-'''Meglumine antimoniate''' (or '''meglumine antimonate''') is a medicine used for treating  [[leishmaniasis]].  It is manufactured by [[Aventis]] and sold as '''Glucantime''' in [[France]], and '''Glucantim''' in [[Italy]].  It belongs to a group of compounds known as the [[pentavalent antimonial]]s. It is administered by [[intramuscular injection]].
-{{Agents against leishmaniasis and trypanosomiasis}}
+{{SK}} Meglumine antimonate
+==Overview==
-[[Category:Antiprotozoal agents]]
+Meglumine antimoniate is a medicine used for treating  [[leishmaniasis]].  It is manufactured by [[Aventis]] and sold as '''Glucantime''' in France, and '''Glucantim''' in Italy.
-{{pharma-stub}}
+It belongs to a group of compounds known as the [[pentavalent antimonial]]s. It is administered by [[intramuscular injection]].
-{{WikiDoc Sources}}
+==Category==
+Antiparasitic
+==Brand Names==
+GLUCANTIM, GLUCANTIME (NOT AVAILABLE)
+==FDA Package Insert==
+'''  [[Meglumine antimoniate description|Description]]'''
+'''| [[Meglumine antimoniate clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[Meglumine antimoniate microbiology|Microbiology]]'''
+'''| [[Meglumine antimoniate indications and usage|Indications and Usage]]'''
+'''| [[Meglumine antimoniate contraindications|Contraindications]]'''
+'''| [[Meglumine antimoniate warnings and precautions|Warnings and Precautions]]'''
+'''| [[Meglumine antimoniate adverse reactions|Adverse Reactions]]'''
+'''| [[Meglumine antimoniate drug interactions|Drug Interactions]]'''
+'''| [[Meglumine antimoniate overdosage|Overdosage]]'''
+'''| [[Meglumine antimoniate clinical studies|Clinical Studies]]'''
+'''| [[Meglumine antimoniate dosage and administration|Dosage and Administration]]'''
+'''| [[Meglumine antimoniate how supplied|How Supplied]]'''
+'''| [[Meglumine antimoniate labels and packages|Labels and Packages]]'''
+==Mechanism of Action==
+==References==
+{{Reflist|2}}
+[[Category:Antibiotics]]
+[[Category:Wikinfect]]